SCHEMBL2709347

SCHEMBL2709347

COc1ccc2c(c1)-c1cnn(C)c1CC2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.47
CYP19A1 P11511 5/20 0.44
CYP11B2 P19099 2/20 0.44
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPT P10636 1/20 0.43
MPI P34949 1/20 0.43
NPY5R Q15761 1/20 0.42
DRD1 P21728 3/20 0.42
DRD5 P21918 3/20 0.42
DRD2 P14416 2/20 0.42
DRD3 P35462 2/20 0.42
TYMS P04818 1/20 0.40
PLK1 P53350 1/20 0.40
CSNK2A1 P68400 1/20 0.40
PLK3 Q9H4B4 1/20 0.40
MAOB P27338 2/20 0.39
HTR2C P28335 1/20 0.39
MAOA P21397 1/20 0.39
DRD4 P21917 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9535703 0.75 PLK1 (0.61) CYP11B2ALDH1A1DRD2PLK1CSNK2A1
SCHEMBL10194591 0.74 PLK1 (0.46) SIGMAR1CYP19A1CYP11B2KDM4EALDH1A1
Hydrochloric Acid SCHEMBL9534437 0.73 PLK1 (0.59) CYP11B2ALDH1A1DRD2PLK1CSNK2A1
SCHEMBL1985114 0.72 DRD2 (0.44) KDM4EALDH1A1MAPTDRD1DRD5
SCHEMBL181850 0.72 STIM1 (0.44) MAPT
SCHEMBL17125335 0.71 SIGMAR1 (0.47) SIGMAR1CYP19A1CYP11B2KDM4EALDH1A1
SCHEMBL17125334 0.69 DRD4 (0.51) SIGMAR1CYP19A1CYP11B2KDM4EALDH1A1
SCHEMBL4895916 0.67 METAP1 (0.61) CYP19A1CYP11B2KDM4EALDH1A1MAPT
SCHEMBL29392039 0.67 MAOB (0.54) CYP19A1KDM4EALDH1A1TYMSMAOB
SCHEMBL1610337 0.67 BCL2 (0.50) SIGMAR1CYP19A1CYP11B2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2363129-A1 Pyrazole or triazole compounds and their use for the manufacture of a medicament for treating somatic mutation-related diseases PTC Therapeutics, Inc. (US) 2011-09-07 EP disclosed
EP-2316452-A1 Pyrrol derivatives, uses thereof PTC Therapeutics, Inc. (US) 2011-05-04 EP disclosed